The Fed just dropped two live grenades on bank stocks simultaneously — stress tests and AML overhaul on the same tape.

The Fed just dropped two live grenades on bank stocks simultaneously — stress tests and AML overhaul on the same tape.

First grenade: stress tests clear. The Fed confirms large banks are capitalized to survive a severe recession and keep lending. That's your green light for buyback announcements and dividend hikes — watch the regionals who were sitting on their hands waiting for this result.

Second grenade: AML program requirements are getting rewritten. The Fed is formally requesting comment on amendments to how banks structure their anti-money laundering compliance. This is not cosmetic. AML overhauls mean compliance cost restructuring, potential consent order exposure for anyone already flagged, and legal reserves moving. CFOs are going to call it a 'proactive alignment with evolving regulatory expectations' — translation: budget pressure you didn't model.

The trader read here is simple — stress test pass is bullish near-term for the big six. The AML proposal is a slow-burn negative for mid-tier banks with thin compliance infrastructure. Those two things are happening at the exact same moment. That spread is where the opportunity lives.

Two separate Fed actions. Two separate risk vectors. Same afternoon. Management will bury the second one in the earnings call. We already found it.

The numbers are the numbers. Management can spin. We don't.